Botulism has long been known but was fi rst described in the 19th century as a rapidly progressing and fatal paralysis following ingestion of blood sausage. It is most notoriously associated with the early days of the food canning industry in the beginning of the 20th century when many outbreaks occurred particularly in the USA. Food-borne botulism remains to this day a cause of regular outbreaks, but the condition can also arise from wound infection or enteric bacterial overgrowth. The responsible bacterium, Clostridium botulinum, was already isolated and identifi ed in the 19th century, but serious research on the purifi cation and crystallization of botulinum toxin type A was carried out only in the cold war era during the search for biological weapons (Schantz and Johnson 1997) . Indeed, botulinum toxin became iconic in modern times as one of Iraq's supposed weapons of mass destruction.
Pinder
Neuropsychiatric Disease and Treatment 2007:3(6) the most exciting aspect for the neuroscientist is the potential neuroprotective effect of botulinum toxin type A in inhibiting enzymes responsible for hippocampal cell death in rats (Manno et al 2007) . From medieval poison to biological weapon to modern therapeutic is quite a transformation, and we await further innovative clinical applications with considerable curiosity and interest.
